Lv61
2140 积分 2025-09-11 加入
Molecular mechanism of SHP2 activation by PD-1 stimulation
1个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
2个月前
已完结
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes
2个月前
已完结
Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer
3个月前
已完结
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes
4个月前
已完结
Homeostatic maturation programs drive human cDC2s into a tolerogenic state
4个月前
已完结
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
7个月前
已完结
T lymphocyte–specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4 + T cells and impairs antitumor response
8个月前
已完结
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
8个月前
已完结
皖公网安备34019202002308
